Pharmacists participating in the trial can:
The management of UTIs and provision of the pill will be conducted under a trial run by the University of Newcastle in association with the University of Technology Sydney, Macquarie University, University of New England, Charles Sturt University, The George Institute for Global Health and the Hunter Medical Research Institute.
The UTI trial commenced in May 2023 with a feasibility study testing the service in real world conditions. From 31 July 2023, the trial expanded to include more than 1000 participating pharmacies. The contraceptive pill trial began in September 2023.
A trial framework ensures that patient safety is promoted and allows the gathering of robust evaluation data. The findings from this trial will inform the role of pharmacists and pharmacies in our healthcare system.
Pharmacists are not able to provide these services outside the trial.
Pharmacies and pharmacists must express interest to participate in the trial.
An expression of interest does not guarantee participation in the trial.
The registration information will be reviewed by the trial research team to ensure eligibility conditions are met, including:
The consultation room or area must:
As part of the trial, specific eligibility criteria are in place to ensure patients receive appropriate care.
If patients do not meet the eligibility criteria to receive the service by their pharmacist as part of the trial, they will be referred to appropriate alternative care, including their GP or an Emergency Department.
Pharmacists must refer to clinical management protocols when assessing a person’s eligibility, assessment and overall management, which may include referral to a GP or an Emergency Department.
For treatment of UTIs, patients must be:
To receive an extended supply of the pill, patients must be:
The trial team will provide additional guidance around inclusion criteria and screening questions if you are accepted to participate in the trial.
Pharmacists are not able to provide these services outside the clinical trial.
To ensure safe care and familiarity with the specific requirements of the trial, all participating pharmacists must complete mandatory training before providing any services.
The trial team will provide you with guidance on training requirements once your participation in the trial is confirmed.
Participating pharmacies and pharmacists need to be registered with the University of Newcastle. Community pharmacies that wish to participate can register their interest.
The registration information will be passed on to the trial research team.
Please note that eligibility conditions apply, including naming the pharmacist(s) who will deliver the service. An expression of interest does not guarantee participation in the trial.
View the Authority allowing participating pharmacists to supply medications (UTI) and the Authority allowing pharmacists to supply medications (Oral contraceptive pill) as part of the trial.
The Authority extends only to pharmacists that are participating in the trial.
For any enquiries about the NSW Pharmacy Trial, email: NSWPharmacyTrial@newcastle.edu.au.
The NSW Pharmacy Trial is registered with the Australian and New Zealand Clinical Trials Registry (ANZCTR). View the Trial registration.
Get answers to:
Or read our:
